Bradley Saenger - 31 Dec 2025 Form 5 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Chief Financial Officer, 10%+ Owner
Signature
/s/ Bradley Saenger
Issuer symbol
TNXP
Transactions as of
31 Dec 2025
Net transactions value
+$9,407
Form type
5
Filing time
17 Feb 2026, 07:00:19 UTC
Previous filing
27 Feb 2025
Next filing
26 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SAENGER BRADLEY Chief Financial Officer, 10%+ Owner 200 CONNELL DRIVE, SUITE 301, BERKELEY HEIGHTS /s/ Bradley Saenger 17 Feb 2026 0001668150

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNXP Common Stock, par value $0.001 Award $9,407 +701 $13.42 701 31 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2025 Employee Stock Purchase Plan.